Living Cell Technologies, Positive Preliminary Data From DiabeCell® Phase I/IIa Trial in Type I Diabetes

October 9, 2007 - Living Cell Technologies Limited (ASX: LCT) released positive preliminary results for its Phase I/IIa clinical trial of the company's proprietary DiabeCell® porcine for the treatment of type 1 diabetes. The clinical trial is being conducted in six type 1 (insulin-dependent) diabetic patients... Living Cell Technologies' Press Release -